Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
Serife Solmaz Medeni
University of Health Sciences Antigua
5Publications
1H-index
4Citations
Publications 5
Newest
Published on Apr 1, 2019in Transfusion and Apheresis Science 1.41
Serdal Korkmaz5
Estimated H-index: 5
(UHSA: University of Health Sciences Antigua),
Serdal Korkmaz2
Estimated H-index: 2
(UHSA: University of Health Sciences Antigua)
+ 46 AuthorsDeniz Goren Sahin1
Estimated H-index: 1
(Istanbul Bilim University)
Abstract Therapeutic plasma exchange (TPE) is used to treat more than 60 diseases worldwide and has drawn growing interest. Little is known about the current situation of TPE activity in Turkey, so we developed a survey to obtain information about this timely topic. We collected data on TPE from 28 apheresis units throughout Turkey. We performed a total of 24,912 TPE procedures with 3203 patients over the past decade. Twenty years ago, the majority of procedures were performed for neurological a...
Published on Apr 3, 2015in Chemotherapy 1.57
Inci Alacacioglu8
Estimated H-index: 8
,
Serife Solmaz Medeni1
Estimated H-index: 1
+ 9 AuthorsMehmet Ali Özcan15
Estimated H-index: 15
Multiple induction regimens have been developed for adult patients with acute lymphoblastic leukemia (ALL). However, there have been no prospective randomized trials that directly compare these regimens. In this study, we wanted to evaluate the outcome of 50 adult ALL patients treated with BFM (i.e. Berlin-Frankfurt-Munster, n = 20) and hyper-CVAD (n = 30) protocols between March 2006 and October 2012. The median age was 25 years in the BFM group and 30.5 years in the hyper-CVAD group with a mal...
Published on Dec 1, 2014
Füsun Özdemirkıran3
Estimated H-index: 3
,
Kadriye Bahriye Payzin3
Estimated H-index: 3
+ 8 AuthorsHayri Özsan4
Estimated H-index: 4
Objective: Classically, chronic intravascular hemolysis, bone marrow failure, thrombosis in Paroxysmal Nocturnal Hemoglobinuria manifested (PNH) is a clonal disorder of hematopoietic stem cells. Eculizimab is a monoclonal antibody for the treatment of PNH, proven to reduce thrombotic episodes and the hemolysis. Us our PNH patients with a rare disease and we wanted to share our experience with eculizumab treatment. Methods: Dokuz Eylul University Faculty of Medicine, hematology USA and the Katip ...
1